Corporate News     12-Dec-23
USFDA inspects Laurus Synthesis' manufacturing unit
Issues five observations under Form 483

Laurus Synthesis (LSPL), a wholly owned subsidiary of Laurus Labs underwent US FDA inspection for the manufacturing facility in Parawada, Anakapalli, near Visakhapatnam, Andhra Pradesh. The inspection was conducted from 4 December 2023 to 12 December 2023.

The subsidiary has been issued a Form 483 with five observations.

Previous News
  Volumes spurt at Laurus Labs Ltd counter
 ( Hot Pursuit - 03-Jul-24   11:00 )
  Laurus Labs Ltd spurts 1.59%
 ( Hot Pursuit - 02-Aug-23   13:05 )
  Laurus Labs inaugurates new R&D center at IKP Knowledge Park
 ( Corporate News - 16-Sep-24   15:32 )
  Laurus Labs slips after US FDA issues Form 483 with five observations to Parawada facility
 ( Hot Pursuit - 13-Dec-23   09:39 )
  Laurus Labs fixes record date for interim dividend
 ( Market Beat - Reports 29-Oct-20   15:50 )
  Laurus Labs Ltd eases for fifth straight session
 ( Hot Pursuit - 07-Sep-22   13:36 )
  Laurus Labs Ltd soars 1.84%, rises for third straight session
 ( Hot Pursuit - 19-Feb-24   13:05 )
  Laurus Lab gains after inks pact to acquire additional stake in ImmunoACT
 ( Hot Pursuit - 01-Jun-23   09:43 )
  Board of Laurus Labs recommends Second Interim Dividend
 ( Corporate News - 28-Apr-23   11:08 )
  Laurus Labs inches up after acquisition
 ( Hot Pursuit - 19-Sep-19   09:21 )
  Laurus Labs Ltd down for fifth straight session
 ( Hot Pursuit - 13-Oct-22   13:35 )
Other Stories
  GAIL (India) signs MoU with AM Green
  04-Oct-24   19:27
  EaseMyTrip.com resumes bookings to the Maldives
  04-Oct-24   19:25
  BLS completes acquisition of Dubai-based Citizenship Invest
  04-Oct-24   19:23
  Insecticides India launches new maize herbicide 'Torry Super'
  04-Oct-24   19:21
  Landmark Cars receives LoI from Mercedes-Benz India
  04-Oct-24   19:19
  Astra Microwave Products receives affirmation in credit ratings from CRISIL
  04-Oct-24   19:16
  Supreme Petrochem receives affirmation in credit ratings
  04-Oct-24   19:10
  Astec LifeSciences director resigns
  04-Oct-24   19:08
  Board of Gravita India approves change in directorate
  04-Oct-24   19:05
  Board of Gravita India approves fund raising up to Rs 1,000 cr
  04-Oct-24   19:03
Back Top